ROCKVILLE, Md.--(Business Wire)--
Emergent BioSolutions Inc. (NYSE:EBS) announced today that Fuad El-Hibri, its
chairman and chief executive officer, received the Ernst & Young Entrepreneur of
the Year® 2009 Award in the Technology category in Greater Washington. According
to Ernst & Young LLP, the award recognizes outstanding entrepreneurs who are
building and leading dynamic, growing businesses. Mr. El-Hibri was selected by
an independent panel of judges and the award was presented at a special gala
event on June 18 at the Ritz-Carlton, Tysons Corner in Virginia.
"It is a tremendous honor to receive this award considering the many
biopharmaceutical and life sciences companies in the greater Washington region,"
said Mr. El-Hibri. "I am proud of Emergent BioSolutions` continuous growth and
financial strength. These successes are firmly anchored on the entrepreneurial
spirit and commitment of our employees. All their contributions, in pursuit of
our company mission to protect life, have made this award possible."
Under Mr. El-Hibri`s leadership, Emergent BioSolutions has expanded its
capabilities in the development and manufacture of vaccines and immune-related
therapeutics. By strengthening its core biodefense portfolio, which includes the
only FDA-licensed vaccine against anthrax disease, Emergent has become the
premier biodefense supplier of medical countermeasures to the U.S. government.
The Ernst & Young Entrepreneur of the Year awards program celebrates its 23rd
anniversary this year and continues to honor entrepreneurs who have demonstrated
excellence in such areas as innovation, financial performance, and personal
commitment to their businesses and communities. The program has expanded to
recognize business leaders in over 135 cities in 50 countries throughout the
world.
As a Greater Washington award winner, Mr. El-Hibri is now eligible for
consideration for the Ernst & Young Entrepreneur of the Year 2009 national
program. Award winners in several national categories, as well as the overall
national Ernst & Young Entrepreneur of the Year award winner, will be announced
at the annual awards gala in Palm Springs, California on November 14, 2009. The
awards are the culminating event of the Ernst & Young Strategic Growth Forum,
the nation`s most prestigious gathering of high-growth, market-leading
companies.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the
development, manufacture and commercialization of vaccines and therapeutics that
assist the body`s immune system to prevent or treat disease. Emergent`s marketed
product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine licensed by
the U.S. Food and Drug Administration for the prevention of anthrax. Emergent`s
development pipeline includes programs focused on anthrax, botulism,
tuberculosis, typhoid, hepatitis B and chlamydia. Additional information may be
found at www.emergentbiosolutions.com.
About Ernst & Young`s Entrepreneur of the Year® Awards Program
Ernst & Young`s Entrepreneur of the Year® Award is the world`s most prestigious
business award for entrepreneurs. The award makes a difference through the way
it encourages entrepreneurial activity among those with potential and recognizes
the contribution of people who inspire others with their vision, leadership and
achievement. As the first and only truly global award of its kind, the Ernst &
Young Entrepreneur of the Year® award celebrates those who are building and
leading successful, growing and dynamic businesses, recognizing them through
regional, national and global awards programs in more than 135 cities in 50
countries.
Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur of the Year awards
are pleased to have the Ewing Marion Kauffman Foundation and SAP America as
national sponsors.
In Greater Washington, sponsors include HSBC Bank, Pillsbury Law, Reznick Group,
Lockton Companies and the Washington Business Journal.
Emergent BioSolutions Inc.
Investors:
Robert G. Burrows, 301-795-1877
Vice President, Investor Relations
BurrowsR@ebsi.com
or
Media:
Tracey Schmitt, 301-795-1800
Vice President, Corporate Communications
SchmittT@ebsi.com
Copyright Business Wire 2009
